 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || 4D-110 / 4D Molecular Therap, Roche
Enrollment closed, Trial completion date, Trial primary completion date: Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia (clinicaltrials.gov) - Jan 19, 2023
P1, N=13, Active, not recruiting, Sponsor: 4D Molecular Therapeutics
Recruiting --> Active, not recruiting | Trial completion date: May 2023 --> Jun 2027 | Trial primary completion date: Nov 2021 --> Jun 2024
- || 4D-110 / 4D Molecular Therap, Roche
New P1 trial: Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia (clinicaltrials.gov) - Jul 22, 2020
P1, N=15, Recruiting, Sponsor: 4D Molecular Therapeutics